InsidersTradesSigma
申报总数
公司
▲ 买入（2 笔）
▼ 卖出（1 笔）
内部人交易记录
高级管理人员已披露买入
2
已披露卖出
1
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Browse the full record of transactions filed by Edwards Martin, Director. Insider active across 3 companies, notably Verona Pharma plc. In total, 10 filings have been recorded. Split: 2 buys · 1 sell. Total volume traded: €111k. Activity tracked since 4 May 2021. The latest transaction was filed on 1 August 2025 (Levée d'options). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Edwards Martin
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报10 总计
157,992 股Ordinary SharesSEC:0001104659-25-097948:0
24,000 股0Ordinary SharesSEC:0001104659-25-074386:0
2,376 股Common StockSEC:0001415889-24-021823:0
33,736 股@ US$1.83787.1% 占其流量Ordinary SharesSEC:0001104659-23-120809:0
标准退出：2024年2月18日 (T+90)
2,376 股@ US$20.54100.0% 占其流量Common StockSEC:0001209191-23-055428:0
标准退出：2024年2月11日 (T+90)
6,116 股Class A common stockSEC:0000899243-23-019533:0
133 股@ US$93.6144.5% 占其流量Class A common stockSEC:0001209191-23-035769:0
359 股@ US$34.7680.4% 占其流量Class A common stockSEC:0001209191-22-035381:0
59 股@ US$27.329.8% 占其流量Class A common stockSEC:0001209191-22-001623:0
12,024 股@ US$0.839712.9% 占其流量Ordinary SharesSEC:0001104659-21-061805:0
10 条申报中的 10 条
About Edwards Martin
Martin Edwards is a Director at Verona Pharma plc and Reata Pharmaceuticals Inc. He participates in the governance of these companies, bringing his expertise in biopharmaceuticals and drug development. His role is essential for guiding strategic decisions and supporting the growth of the companies.
